MedPath

The Effects of Portulaca oleracea Extract capsule on inflammatory biomarkers, lipid profile and serum glucose, anthropometric indices and blood pressure

Phase 1
Conditions
Metabolic syndrome.
Obesity, unspecified
Registration Number
IRCT2014121920366N1
Lead Sponsor
Vice chancellor for research,Isfahan University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

persons suffering from obesity as defined by the IDF (WC= 102 in men) and have 2 signs of the 4 following symptoms, the metabolic syndrome was diagnosed. In this study, the characteristics of metabolic syndrome will be considered, if the criteria were the terms of this syndrome (having 2 of the first 4), other criteria will be checked:
1-high blood pressure (systolic>130mhg and diastolic>85mmhg); 2-fasting blood glucose>100mg/dl; 3-TG>150mg/dl; 4-HDL<40mg/dl; -gender: male; no history of cancer, kidney, thyroid, diabetes, and anemia; lack of use of alcohol and drugs; no smoking history or drug allergy; no special diet; no change in medication in the last three months; lack of drugs that control blood sugar, lipid and blood pressure; no taking medications affecting inflammation, such as corticosteroids.
Exclusion criteria: during the study , patients who lose their inclusion criteria, including smoking; suffering from diseases such as heart problems , kidney , thyroid and digestive disorders and lack of cooperation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath